Tetrac

Modify Date: 2025-08-25 10:43:23

Tetrac structure	Common Name	Tetrac
	CAS Number	67-30-1	Molecular Weight	747.82900
	Density	2.727g/cm3	Boiling Point	544.8ºC at 760 mmHg
	Molecular Formula	C₁₄H₈I₄O₄	Melting Point	230 °C
	MSDS	Chinese USA	Flash Point	283.3ºC
	Symbol	GHS06	Signal Word	Danger

Use of Tetrac

Tetrac (Tetraiodothyroacetic acid), a deaminated analogue of L-thyroxine (T4), and is a thyrointegrin receptor antagonist. Tetrac blocks the actions of T3 and T4 as well as different growth factors-mediated angiogenesis. Tetra also has anticancer activity[1][2].

Name	2-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]acetic acid
Synonym	More Synonyms

Description	Tetrac (Tetraiodothyroacetic acid), a deaminated analogue of L-thyroxine (T4), and is a thyrointegrin receptor antagonist. Tetrac blocks the actions of T3 and T4 as well as different growth factors-mediated angiogenesis. Tetra also has anticancer activity[1][2].
Related Catalog	Research Areas >> Cancer
In Vitro	Tetrac (0.01-1 μM; 2-6 d) induces anti-proliferation in HT-29 and HCT116 cells with different K-RAS status[3]. Tetrac (0.1 μM; 30 min) inhibits activation of ERK1/2 in HT-29 and HCT116 cells[3]. Tetrac (0.1 μM; 24 h) inhibits expression of CCND1 and c-Myc, but promotes expression of CASP2 and THBS1[3]. Cell Proliferation Assay[3] Cell Line: HT-29 and HCT116 cells Concentration: 0.01, 0.1, 1 μM Incubation Time: 0, 2, 4, 6 days Result: Induced anti-proliferation of K-RAS wild-type colorectal cancer cells. Western Blot Analysis[3] Cell Line: HT-29 and HCT116 cells Concentration: 0.1 μM Incubation Time: 30 min Result: Inhibited constitutively activated ERK1/2, and this inhibition can remove by anti-integrin αvβ3 antibody pretreatment.
In Vivo	Tetrac (35 μg; p.o. for 40 days) inhibits tumor inoculation, growth and integrin expression in mice[4]. Animal Model: Wild-type male Balb/C mice aged 8 weeks are inoculated with 102B16F10 or B16LS9 cells[4] Dosage: 35 μg per day Administration: P.o. (added to the drinking water) daily for 40 days Result: Delayed the onset of ocular melanoma. Reduced the S-100 and integrin staining level in the B16F10 mice model.
References	[1]. Schmohl KA, et, al. Tetrac as an anti-angiogenic agent in cancer. Endocr Relat Cancer. 2019 Jun 1; 26(6):R287-R304. [2]. Davis PJ, et, al. Nongenomic Actions of Thyroid Hormone: the Integrin Component. Physiol Rev. 2020 Jun 25. [3]. Chin YT, et, al. Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different K-RAS Status. Front Endocrinol (Lausanne). 2019 Mar 12; 10:130. [4]. Ashur-Fabian O, et, al. Tetrac Delayed the Onset of Ocular Melanoma in an Orthotopic Mouse Model. Front Endocrinol (Lausanne). 2019 Jan 8; 9:775. [5]. Rajabi M, et, al. Synthesis of new analogs of tetraiodothyroacetic acid (tetrac) as novel angiogenesis inhibitors for treatment of cancer. Bioorg Med Chem Lett. 2018 Apr 15;28(7):1223-1227.

Density	2.727g/cm3
Boiling Point	544.8ºC at 760 mmHg
Melting Point	230 °C
Molecular Formula	C₁₄H₈I₄O₄
Molecular Weight	747.82900
Flash Point	283.3ºC
Exact Mass	747.66000
PSA	66.76000
LogP	5.23000
Index of Refraction	1.801

Symbol	GHS06
Signal Word	Danger
Hazard Statements	H300
Precautionary Statements	P264-P301 + P310
Personal Protective Equipment	Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges
Hazard Codes	T+
Risk Phrases	28
Safety Phrases	45
RIDADR	UN 2811 6.1/PG 1
RTECS	CY1585800
Hazard Class	6.1
HS Code	2918990090

3,5-Diiodothyro...

CAS#:1155-40-4

~90%

Tetrac

CAS#:67-30-1

Literature: Bridoux, Alexandre; Khan, Riaz A.; Chen, Celei; Cheve, Gwenael; Cui, Huadong; Dyskin, Evgeny; Yasri, Aziz; Mousa, Shaker A. Journal of Enzyme Inhibition and Medicinal Chemistry, 2011 , vol. 26, # 6 p. 871 - 882

(4-hydroxy-3,5-...

CAS#:83799-60-4

Tetrac

CAS#:67-30-1

Literature: US2011/105482 A1, ;

[4-(4-methoxy-p...

CAS#:861065-72-7

Tetrac

CAS#:67-30-1

Literature: US2011/105482 A1, ;

Mequinol

CAS#:150-76-5

Tetrac

CAS#:67-30-1

Literature: US2011/105482 A1, ;

ethyl 3,5-diiod...

CAS#:85828-82-6

Tetrac

CAS#:67-30-1

Literature: Biochemical Journal, , vol. 63, p. 601,603

ethyl 2-(3,5-di...

CAS#:101588-11-8

Tetrac

CAS#:67-30-1

Literature: US2011/105482 A1, ;

1-(4-chlorometh...

CAS#:860687-73-6

Tetrac

CAS#:67-30-1

Literature: Biochemical Journal, , vol. 50, p. 438

[3,5-diiodo-4-(...

CAS#:855937-68-7

Tetrac

CAS#:67-30-1

Literature: Biochemical Journal, , vol. 50, p. 438

Precursor 8
CAS#:1155-40-4 3,5-Diiodothyro... CAS#:83799-60-4 (4-hydroxy-3,5-... CAS#:861065-72-7 [4-(4-methoxy-p... CAS#:150-76-5 Mequinol
CAS#:85828-82-6 ethyl 3,5-diiod... CAS#:101588-11-8 ethyl 2-(3,5-di... CAS#:860687-73-6 1-(4-chlorometh... CAS#:855937-68-7 [3,5-diiodo-4-(...
DownStream 0

HS Code	2918990090
Summary	2918990090. other carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

Tetraiodothyroacetic acid-tagged liposomes for enhanced delivery of anticancer drug to tumor tissue via integrin receptor

J. Control. Release 164(2) , 213-20, (2012)

Nanoparticles have demonstrated potential for promoting drug delivery to tumor sites and enhancing uptake. Here, we report tetraiodothyroacetic acid (tetrac) as a promising new targeting moiety for de...

Tetraiodothyroacetic acid and tetraiodothyroacetic acid nanoparticle effectively inhibit the growth of human follicular thyroid cell carcinoma.

Thyroid 20(3) , 281-6, (2010)

Tetraiodothyroacetic acid (tetrac) is a deaminated analogue of L-thyroxine that blocks the actions of L-thyroxine and 3,5,3'-triiodo-L-thyronine at the cell surface receptor for thyroid hormone on int...

Tetraiodothyroacetic acid and its nanoformulation inhibit thyroid hormone stimulation of non-small cell lung cancer cells in vitro and its growth in xenografts.

Lung Cancer 76(1) , 39-45, (2012)

Thyroid hormone stimulates cell proliferation of several types of cancers and stimulates cancer-relevant angiogenesis. In the present study, we investigated the proliferative effect of thyroid hormone...

5-diiodophenoxy)-3

Thyroacetic acid,3,3',5,5'-tetraiodo

3,5-Diiodo-4-(4-hydroxy-3,5-diiodophenoxy)benzeneacetic acid

Tetrac

MFCD00055932

[4-(4-hydroxy-3

4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenylacetic acid

Benzeneacetic acid,3,5-diiodo-4-(4-hydroxy-3,5-diiodophenoxy)

3,3',5,5'-TETRAIODOTHYROACETIC ACID

Tetraiodothyroacetic acid

Acide 3,5,3',5'-tetraiodothyroacetique [French]

5-diiodophenyl] acetic acid

EINECS 200-649-1

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

Shanghai Nianxing Industrial Co., Ltd
China
Product Name: Tetrac
Price: Check
Purity: 98.0%
Delivery: 10 Day
Contact: Yang
Email: sales@echemcloud.com

Shanghai Jizhi Biochemical Technology Co., Ltd
China
Product Name: Tetrac
Price: ￥888.0/25mg ￥2288.0/100mg ￥8068.0/500mg
Purity: 98.0%
Delivery: Inquiry
Contact: Liu jia
Email: 2130147988@qq.com

DC Chemicals Limited
China
Product Name: Tetrac
Price: $Inquiry/250mg $Inquiry/100mg $Inquiry/1g
Purity: 98.0%
Delivery: 3 Day
Contact: Tony Cao
Email: sales@dcchemicals.com

Dayang Chem (Hangzhou) Co., Ltd.
China
Product Name: 4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenylacetic acid
Price: $Inquiry/100g $Inquiry/1kg $Inquiry/100kg $Inquiry/1000kg
Purity: 98.0%
Delivery: Inquiry
Contact: Ms Wang
Email: enquiry@dycnchem.com

Get all suppliers and price by the below link:

Tetrac suppliers

Tetrac price

Tetrac

Use of Tetrac

Names

Tetrac Biological Activity

Chemical & Physical Properties

Safety Information

Synthetic Route

Precursor & DownStream

Customs

Articles28

Synonyms

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.